ANTITHROMBOTIC ACTIONS OF SELECTIVE INHIBITORS OF BLOOD COAGULATION FACTOR Xa IN RAT MODELS OF THROMBOSIS
- 15 July 1996
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 83 (2) , 117-126
- https://doi.org/10.1016/0049-3848(96)00112-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitorThrombosis Research, 1995
- Antithrombotic Effects of Orally Active Synthetic Antagonist of Activated Factor X in Nonhuman PrimatesCirculation, 1995
- DX-9065aDrugs of the Future, 1995
- Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa InhibitorsJournal of Medicinal Chemistry, 1994
- Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosisThrombosis Research, 1993
- Enhancement of recombinant tissue plasminogen activator-induced reperfusion by recombinant tick anticoagulant peptide, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosisFibrinolysis, 1993
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- Antithrombotic efficacy of recombinant tick anticoagulant peptide. A potent inhibitor of coagulation factor Xa in a primate model of arterial thrombosis.Circulation, 1991
- Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor X.alpha.Biochemistry, 1990
- Tick Anticoagulant Peptide (TAP) Is a Novel Inhibitor of Blood Coagulation Factor XaScience, 1990